Seattle Genetics Appoints Roger D. Dansey, M.D., Chief Medical Officer

BOTHELL, Wash.–(BUSINESS WIRE)–May 17, 2018– Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointment of Roger D. Dansey, M.D., as Chief Medical Officer. Dr. Dansey brings extensive experience in cancer drug development, most recently from Merck Inc. where he was Therapeutic Area Head for Late

Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting

BOTHELL, Wash.–(BUSINESS WIRE)–May 17, 2018– Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that multiple abstracts from its robust clinical development portfolio will be presented at the upcoming 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, from June 1-5, 2018. “The abstracts